Editor's Picks (Total records: loading...)
John Engle
No One Wants to Pop the Asset Bubble
(Status: Pending)
The Fed is playing a very dangerous game Jul 30, 2019 β
β
β
β
β
Stepan Lavrouk
What Can Investors Expect From the Coming Rate Cut?
(Status: Pending)
A discussion of how the market could react Jul 30, 2019
Ben Reynolds
One of the Highest-Yielding Stocks in the S&P 500
(Status: Pending)
Macy's has a high 6.6% dividend yield. The company is investing heavily to return to growth, which will help secure the dividend going forward Jul 30, 2019
Smead Capital Management
Munger and Icahn Make Oil Investing 'Easy'
(Status: Pending)
If Buffett, Munger, Icahn and a slew of insiders at Occidental Petroleum are correct, buying the stock here is easy Jul 30, 2019 β
β
β
β
β
Sydnee Gatewood
Merck Shares Rise on Strong Sales Growth
Drugmaker revises revenue, earnings guidance Jul 30, 2019
Rupert Hargreaves
Revisiting Ben Graham's Asset Allocation Policy
Looking back at the performance of Graham's recommended asset-allocation policy Jul 30, 2019
James Li
Beyond Meat Tumbles on Secondary Public Offering, 2nd-Quarter Net Loss
Meat-alternative producer continues skyrocketing sales Jul 29, 2019
Holly LaFon
Boyar Funds Commentary: Is CVS a Value Trap or a Fallen Angel Ready to Rise Again?
By Jonathan Boyar Jul 29, 2019
Rupert Hargreaves
David Einhorn Is Still Betting on Brighthouse
(Status: Pending)
The value investor discusses one of his favorite positions in his 2nd-quarter letter to investors Jul 29, 2019 β
β
β
β
β
Sydnee Gatewood
Pfizer to Combine Off-Patent Drug Business With Mylan
(Status: Pending)
The all-stock deal will create new pharmaceutical company Jul 29, 2019
Ben Reynolds
Kroger: Recession-Resistant Consumer Staples Dividend Stock
Kroger is investing for growth, while returning loads of cash to shareholders Jul 29, 2019
Stepan Lavrouk
Buffett on Using Options as Compensation
The Oracle of Omaha takes issue with the idea that options have no cost Jul 29, 2019
Thomas Macpherson
An Agonizing Reappraisal
The last decade has challenged some of value investing's most cherished first principles. Here is how Nintai Investments sees this and how we are dealing with it Jul 29, 2019 β
β
β
β
β
Matthew Sipos
Value Idea Contest: Is Teva Pharmaceutical Industries Ltd. a Buffett bargain?
Should you follow the footsteps of Berkshire's protΓΒ©gΓΒ©es in this case? Jul 29, 2019 β
β
β
β
β
Bram de Haas
Dan Loeb: No Recession on the Immediate Horizon
A review of famous (activist) investor Dan Loeb's latest letter to investors Jul 28, 2019 β
β
β
β
β
John Engle
Ray Dalio Says the Fed Is Almost Out of Firepower
Bridgewater's founder foresees major challenges during the next downturn Jul 28, 2019
Alberto Abaterusso
2-High Performing Stocks for the Value Investor
Peter Lynch indicates these dividend payers are not expensive Jul 28, 2019
Stepan Lavrouk
Howard Marks: Doing the Right Thing at the Right Time
It turns out it's almost impossible to do so Jul 28, 2019 β
β
β
β
β
More GuruFocus Links
All-In-One Screener Latest Guru Picks Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger ScreenerLatest Comments
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers